To further confirm this phenomenon, we analyzed the lung cancer patient data in the GEO database and found that patients with higher expression of SPP1 had poorer overall survival rate (Figure 2C), and patients with higher expression of SPP1 also had poorer first progression (Figure 2D). This evidence concerns the gene SPP1 and lung carcinoma.